OMER Omeros Corporation

USD 7.30 +0.33 ( +4.73%)
Icon

Omeros Corporation (OMER) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 7.30

+0.33 (+4.73%)

USD 0.53B

0.35M

USD 9.00(+23.29%)

N/A

Icon

OMER

Omeros Corporation (USD)
COMMON STOCK | NSD
USD 7.30
+0.33 ( +4.73%)

Omeros Corporation (OMER) Annual Income Statement (USD)

OMER Quarterly Financials (USD)

Frequently Asked Questions About Omeros Corporation (OMER) Stock

Omeros Corporation's (OMER) last reported annual revenue was USD 0.00.

Omeros Corporation's (OMER) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Omeros Corporation's(OMER) is not profitable as of its last reported annual financials.

The net profit margin for Omeros Corporation's(OMER) from its laster reported year is N/A

The return on equity (ROE) for Omeros Corporation's(OMER) from its last reported annual financials is : -576.33%

The return on assets (ROA) for Omeros Corporation's(OMER) from its last reported annual financials is : -26.87%

The return on invested capital (ROIC) for Omeros Corporation's(OMER) from its last reported annual financials is : -57.14%

The Debt to Equity ratio for Omeros Corporation's(OMER) from its last reported annual financials is : 0.00%

The dividend yield for Omeros Corporation's(OMER) from its laster reported year is 0.00%

Omeros Corporation's(OMER) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...